Business Segments Sarepta Therapeutics, Inc.

Equities

SRPT

US8036071004

Pharmaceuticals

Market Closed - Nasdaq 01:30:00 17/07/2025 am IST After hours 03:03:07 am
18.38 USD +0.93% Intraday chart for Sarepta Therapeutics, Inc. 24.08 +31.01%

Sales 2024 by Business Segment

See more © MarketScreener.com

Sales 2024 by Geography

See more © MarketScreener.com

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Breakdown by Business Segment (USD)
Fiscal Period: December2015201620172018201920202021202220232024

Gene Research and Development

          

Discovering, Developing, Manufacturing and Delivering Therapies

54Cr 70Cr 93Cr 124.33Cr 190.2Cr

Total Assets

298.47Cr 314.8Cr 312.84Cr 326.46Cr 396.32Cr

Interest Expense

-5.99Cr -6.35Cr -5.32Cr -2.2Cr -1.84Cr

Income Tax Expense

10.63L -2L 1.35Cr 1.59Cr 2.55Cr

CAPEX

-8.22Cr -3.85Cr -3.08Cr -7.61Cr -14Cr

EBT

-55Cr -42Cr -69Cr -52Cr 26Cr

D&A

2.69Cr 3.79Cr 4.18Cr 4.44Cr 3.77Cr

Operating Income

-56Cr -46Cr -54Cr -27Cr 22Cr

Net Income

-55Cr -42Cr -70Cr -54Cr 24Cr

Geographical Revenue Distribution History

Geographical breakdown of sales (USD)
Fiscal Period: December2015201620172018201920202021202220232024

United States

54Cr 70Cr 93Cr 124.33Cr 190.2Cr

Total Assets

298.47Cr 314.8Cr 312.84Cr 326.46Cr 396.32Cr

Interest Expense

-5.99Cr -6.35Cr -5.32Cr -2.2Cr -1.84Cr

Income Tax Expense

10.63L -2L 1.35Cr 1.59Cr 2.55Cr

D&A

2.69Cr 3.79Cr 4.18Cr 4.44Cr 3.77Cr

CAPEX

-8.22Cr -3.85Cr -3.08Cr -7.61Cr -14Cr

Net Income

-55Cr -42Cr -70Cr -54Cr 24Cr

EBT

-55Cr -42Cr -69Cr -52Cr 26Cr

Operating Income

-56Cr -46Cr -54Cr -27Cr 22Cr